Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Axcelis Technologies, Inc. - Common Stock
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
Paycor HCM, Inc. - Common Stock
Quality Systems, Inc. - Common Stock
Zynga Inc. - Class A Common Stock
Edit Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Articles published by Revolution Medicines, Inc.
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
July 07, 2026
From
Revolution Medicines, Inc.
Via
GlobeNewswire
Tickers
RVMD
Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer
April 13, 2026
From
Revolution Medicines, Inc.
Via
GlobeNewswire
Tickers
RVMD
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
November 07, 2022
From
Revolution Medicines, Inc.
Via
GlobeNewswire
Tickers
RVMD
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.